KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Goodwill (2016 - 2025)

Historic Goodwill for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $21.6 billion.

  • Merck's Goodwill fell 50.7% to $21.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 billion, marking a year-over-year decrease of 50.7%. This contributed to the annual value of $21.7 billion for FY2024, which is 222.2% up from last year.
  • Merck's Goodwill amounted to $21.6 billion in Q3 2025, which was down 50.7% from $21.6 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Goodwill peaked at $21.7 billion during Q3 2024, and registered a low of $18.9 billion during Q3 2021.
  • Its 5-year average for Goodwill is $21.0 billion, with a median of $21.2 billion in 2022.
  • Over the last 5 years, Merck's Goodwill had its largest YoY gain of 779665.27% in 2021, and its largest YoY loss of 684.51% in 2021.
  • Merck's Goodwill (Quarter) stood at $21.3 billion in 2021, then fell by 0.28% to $21.2 billion in 2022, then fell by 0.03% to $21.2 billion in 2023, then rose by 2.22% to $21.7 billion in 2024, then dropped by 0.37% to $21.6 billion in 2025.
  • Its last three reported values are $21.6 billion in Q3 2025, $21.6 billion for Q2 2025, and $21.7 billion during Q1 2025.